Plus Therapeutics Inc.

0.66
-0.06 (-8.97%)
At close: Mar 03, 2025, 3:59 PM
0.66
-0.33%
After-hours: Mar 03, 2025, 07:08 PM EST

Plus Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98
Net Income -13.32M -20.27M -13.4M -8.24M -10.89M -12.63M -22.69M -22.05M -18.74M -37.37M -26.18M -32.28M -32.45M -27.49M -23.22M -30.04M -28.67M -25.45M -26.54M -2.09M -9.13M -13M -11.21M -8.64M -4.57M -2.09M
Depreciation & Amortization 628K 619K 395K 366K 896K 2M 2.15M 1.18M 1.09M 779K 1.63M 933K 855K 931K 1.68M 1.71M 1.62M 2.12M 1.72M 824K 1.66M 1.47M 1.18M 441K n/a n/a
Stock-Based Compensation 569K 606K 606K 247K 127K 355K 753K 1.08M 2.04M 3.1M 3.61M 3.9M 3.32M 3.06M 2.65M 2.31B 2.31B 3.22B 404M 119M 997M 1.3B 1.14B n/a n/a n/a
Other Working Capital 2.56M -855K -496K 77K 29K 90K -600K -391K -286K 1.15B 405.81M 1.43B 1.43B -809.45M 2.21B -2.05B -5.48M -871.57M -3.05B -35.82M -283.4M 316.97M -20.95M -328K n/a n/a
Other Non-Cash Items 384K 481K 820K 1.37M 1.79M 1.05M 2.39M 978K 1.34M 1.8M 1.1M 930K -35.59M -795K 4.29M 3.39M 2.31M -666K 3.03M -13.52M -692K 5.54M 2.81M 6.69M -536K 567K
Deferred Income Tax n/a n/a 60K -2.29M 3.1M -1.72M 298K 45K -7.5M 995K -9.86M 440K 33.37M 854K 753K -2.31B -2.31B -3.22B -404M -119M -997M -1.3B -1.14B n/a n/a n/a
Change in Working Capital -1.12M 5.6M 1.24M 119K -938K -1.03M -1.04M -772K 1.3M 364K -4.86M -6.12M -4.83M -125K -9.97M -8.5M -3.5M 7.44M 20.68M 2.21M 920K -893K -1.1M -1.47M n/a n/a
Operating Cash Flow -12.85M -12.97M -10.28M -8.43M -5.91M -11.97M -18.13M -19.53M -20.47M -30.33M -34.56M -32.19M -35.32M -23.57M -23.81M -33.39M -30M -16.48M -1.1M -12.57M -7.25M -6.89M -8.32M -2.98M -5.11M -1.52M
Capital Expenditures -160K -509K -144K -493K -67K -133K -1.5M -67K -624K -1.02M -519K -1.2M -560K -610K -221K -393K -563K -3.14M -1.85M -789K -1.74M -909K -2.66M -2.73M n/a n/a
Acquisitions n/a -250K 62K -400K 5.64M n/a 113K 131K 11K n/a 5M n/a n/a n/a n/a -2.57B 3.17M 150M n/a -28K -654K -2.9M 1B n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -330K -5.74B -5.74M -24.33M -63.41M -54.06M -50.32M -41.27M -56.97M -85.14M -122.33M n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.74B 5.74M 28.01M 67.14M 56.82M 51.13M 49.56M 68.15M 90.06M 85.61M n/a n/a
Other Investing Acitivies n/a -250K 62K 400K 5.64M n/a -212K 131K 11K -324K -800K n/a n/a -350K n/a 2.57B -305K -150M 1K 13.43M 57K 9.88M -1B n/a -381K -598K
Investing Cash Flow -160K -759K -82K -493K 5.57M -133K -1.71M 64K -613K -1.34M 3.69M -1.2M -560K -1.29M -221K -393K 5.98M 591K 911K 13.43M 5.95M 17.27M 2.26M -39.45M -381K -598K
Debt Repayment -1.61M -1.61M -276K -5.42M -3.82M n/a -4.72M n/a -7.33M -1.96M 4.7M -2.69M 4.92M 14.55M -2.05M 6.03M -1.2M -352K 444K 192K 694K -1.42M 2.23M -105K n/a n/a
Common Stock Repurchased -126K n/a n/a n/a n/a n/a -2.08M n/a n/a n/a n/a n/a n/a n/a -1.34M -850K n/a n/a n/a -1.05M -2.27M -7.44M -1.08M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a -75K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -348K -773K 2.02M 1.1M 490K -66K n/a -3.86M -850K 13.84M 16.08M -69K 1.94M 4.65M 531K 795K -1.6M n/a n/a n/a n/a n/a 1.28B 4.09M 7.92M 1.84M
Financial Cash Flow 3.44M 13.45M 20.42M -319K 12.63M 7.17M 16.82M 17.61M 20.8M 30.87M 20.77M 22.19M 20.14M 64.68M 24.27M 34.93M 26.58M 16.79M 5.36M -831K -997K -7.97M 1.28M 47.44M 7.92M 1.84M
Net Cash Flow -9.57M -280K 10.05M -9.25M 12.29M -4.92M -3.01M -1.78M -284K -884K -10.21M -11.21M -15.75M 39.81M 243K 1.15M 2.56M 895K 5.17M 20K -2.29M 2.41M -4.78M 5M 7.92M 1.84M
Free Cash Flow -13.01M -13.48M -10.42M -8.93M -5.97M -12.11M -19.62M -19.6M -21.09M -31.35M -35.08M -33.4M -35.88M -24.18M -24.03M -33.78M -30.56M -19.62M -2.95M -13.36M -8.99M -7.79M -10.99M -5.71M -5.11M -1.52M